Barriers to pre-treatment genomic characterization of the small renal mass

por Syed, Jamil S., Lebacle, Cedric, Shuch, Brian
Publicado 2019

Whole-genome analysis of papillary kidney cancer finds significant noncoding alterations

por Li, Shantao, Shuch, Brian M., Gerstein, Mark B.
Publicado 2017

Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials

por Wilkins, Jon F., Cannataro, Vincent L., Shuch, Brian, Townsend, Jeffrey P.
Publicado 2018

Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass Spectrometry

por Bao, Xun, Wu, Jianmei, Shuch, Brian, LoRusso, Patricia, Bindra, Ranjit S., Li, Jing
Publicado 2019

Targeting the mTOR pathway in Chromophobe Kidney Cancer

por Shuch, Brian, Vourganti, Srinivas, Friend, Julia C., Zehngebot, Lee M., Linehan, W. Marston, Srinivasan, Ramaprasad
Publicado 2012

Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database

por Vourganti, Srinivas, Harbin, Andrew, Singer, Eric A., Shuch, Brian, Metwalli, Adam R., Agarwal, Piyush K.
Publicado 2013

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors

por Shuch, Brian, Falbo, Ryan, Parisi, Fabio, Adeniran, Adebowale, Kluger, Yuval, Kluger, Harriet M., Jilaveanu, Lucia B.
Publicado 2015

CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells

por Trac, Noah, Oh, Hyun Seok, Jones, Leila Izzy, Caliliw, Randy, Ohtake, Shinji, Shuch, Brian, Chung, Eun Ji
Publicado 2022

MET Inhibition in Clear Cell Renal Cell Carcinoma

por Xie, Zuoquan, Lee, Young H., Boeke, Marta, Jilaveanu, Lucia B., Liu, Zongzhi, Bottaro, Donald P., Kluger, Harriet M., Shuch, Brian
Publicado 2016

Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography

por Uhlig, Johannes, Leha, Andreas, Delonge, Laura M., Haack, Anna-Maria, Shuch, Brian, Kim, Hyun S., Bremmer, Felix, Trojan, Lutz, Lotz, Joachim, Uhlig, Annemarie
Publicado 2020

Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL

por Arevalo, Aileen, Patel, Neal, Muraki, Peter, Ohtake, Shinji, Bratslavsky, Gennady, Clark, Chandra, Mann, Joshua, Iliopoulos, Othon, Jonasch, Eric, Srinivasan, Ramaprasad, Shuch, Brian
Publicado 2022

Racial disparities in renal cell carcinoma: a single‐payer healthcare experience

por Mafolasire, Abiodun, Yao, Xiaopan, Nawaf, Cayce, Suarez‐Sarmiento, Alfredo, Chow, Wong‐Ho, Zhao, Wei, Corley, Douglas, Hofmann, Jonathan N., Purdue, Mark, Adeniran, Adebowale J., Shuch, Brian
Publicado 2016

Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate‐risk clear cell kidney cancer

por Patel, Neal, Hakansson, Alexander, Ohtake, Shinji, Muraki, Peter, Proudfout, James A., Liu, Yang, Webber, Lisa, Ibarra, Arkaitz, Liu, Vinnie Y. T., Davicioni, Elai, Chamie, Karim, Pantuck, Allan, Shuch, Brian
Publicado 2022

Multi-kinase inhibitors can associate with heat shock proteins through their NH(2)-termini by which they suppress chaperone function

por Booth, Laurence, Shuch, Brian, Albers, Thomas, Roberts, Jane L., Tavallai, Mehrad, Proniuk, Stefan, Zukiwski, Alexander, Wang, Dasheng, Chen, Ching-Shih, Bottaro, Don, Ecroyd, Heath, Lebedyeva, Iryna O., Dent, Paul
Publicado 2016

Leukocyte telomere length and renal cell carcinoma survival in two studies

por Callahan, Catherine L, Schwartz, Kendra, Ruterbusch, Julie J, Shuch, Brian, Graubard, Barry I, Lan, Qing, Cawthon, Richard, Baccarelli, Andrea A, Chow, Wong-Ho, Rothman, Nathaniel, Hofmann, Jonathan N, Purdue, Mark P
Publicado 2017

Oncometabolites suppress DNA repair by disrupting local chromatin signaling

por Sulkowski, Parker L., Oeck, Sebastian, Dow, Jonathan, Economos, Nicholas G., Mirfakhraie, Lily, Liu, Yanfeng, Noronha, Katelyn, Bao, Xun, Li, Jing, Shuch, Brian M., King, Megan C., Bindra, Ranjit S., Glazer, Peter M.
Publicado 2020

Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma

por Yang, Youfeng, Lane, Andrew N., Ricketts, Christopher J., Sourbier, Carole, Wei, Ming-Hui, Shuch, Brian, Pike, Lisa, Wu, Min, Rouault, Tracey A., Boros, Laszlo G., Fan, Teresa W.-M., Linehan, W. Marston
Publicado 2013

Krebs Cycle-Deficient Hereditary Cancer Syndromes are Defined by Homologous Recombination DNA Repair Defects

por Sulkowski, Parker L., Sundaram, Ranjini K., Oeck, Sebastian, Corso, Christopher D., Liu, Yanfeng, Noorbakhsh, Seth, Niger, Monica, Boeke, Marta, Ueno, Daiki, Kalathil, Aravind Nambiar, Bao, Xun, Li, Jing, Shuch, Brian, Bindra, Ranjit S., Glazer, Peter M.
Publicado 2018

Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy

por Ueno, Daiki, Vasquez, Juan C., Sule, Amrita, Liang, Jiayu, van Doorn, Jinny, Sundaram, Ranjini, Friedman, Sam, Caliliw, Randy, Ohtake, Shinji, Bao, Xun, Li, Jing, Ye, Huihui, Boyd, Karla, Huang, Rong Rong, Dodson, Jack, Boutros, Paul, Bindra, Ranjit S., Shuch, Brian
Publicado 2022

Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells

por Kang, Min, Chong, Kay Yi, Hartwich, Tobias M. P., Bi, Fangfang, Witham, Allyson K., Patrick, David, Morrisson, Madeline J., Cady, Sarah L., Cerchia, Alexandra P., Kelk, Dawn, Liu, Yifei, Nucci, Jonah, Madarikan, Oluwagbemisola, Ueno, Daiki, Shuch, Brian M., Yang-Hartwich, Yang
Publicado 2020